Japan Coronary Stents Market Size, Share, Growth & Trends Forecast 2025–2033 {{ currentPage ? currentPage.title : "" }}

Japan Coronary Stents Market Overview

Market Size and Growth

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 685.0 Million

Market Forecast in 2033: USD 1,026.8 Million

Market Growth Rate: 4.37% (2025-2033)

According to the latest report by IMARC Group, the Japan coronary stents market size reached USD 685.0 million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,026.8 million by 2033, exhibiting a CAGR of 4.37% from 2025 to 2033.

japan coronary stents market

Japan Coronary Stents Industry Trends and Drivers

The coronary stents market in Japan is characterized by a rapid acceptance of drug-eluting stents, an increasing use of IVUS and optical coherence tomography imaging platforms to guide PCI, and national reimbursement policies favoring high-grade outcomes in the long-term. PCI with IVUS or OCT guidance is performed in 85% of these procedures, to guide sizing, expansion, and apposition, showing national preferences toward imaging, stenting, decreasing complications, and sustaining long-term patency in the elective setting. In addition to "workhorse" monofocal stents, newer premium platforms include polymer, thin struts and drug-eluting coating strategies for co-planned interventional management of the non-culprit lesions. Such "bioresorbable scaffolds" (scaffolds which disappear once they have served their purpose), systems are now being introduced but with more strict protocols and training to ensure that new technologies are safe and effective along with minimizing the threat of thrombosis complications.

Market access through a set of national pricing approval schemes, PDMA processes, PMS guidance and reimbursement and clinical evidence for single and post-approval use when safety can be conclusively demonstrated, and post-market conditions highlighted by peer review with high-quality clinical evidence should be in a good position to respond to new products in a range of interventional modalities. Cardiovascular industry vendors that can achieve commercialization and vendor-agnostic solutions across a range of interventional modalities for contemporary Japanese market segmented into organized programs of integration around drug-eluting systems, imaging and physiology tools industry, and integrated systems for complete circle training on lesion preparation and post dilatation of stents with a focus on precise deployment, predictable healing, and sound patient counseling on antiplatelet management and trade-offs with procedure risk and otherwise unfamiliar technologies.

Request for a Sample Copy of the Report: https://www.imarcgroup.com/japan-coronary-stents-market/requestsample

Japan Coronary Stents Market Segmentation

The market report offers a comprehensive analysis of the segments, highlighting those with the largest Japan coronary stents market share. It includes forecasts for the period 2025-2033 and historical data from 2019-2024 for the following segments:

Type Insights:

  • Drug-Eluting Stents

  • Bare-Metal Coronary Stents

  • Bioabsorbable Stents

Biomaterial Insights:

  • Metallic Biomaterial

  • Polymeric Biomaterial

  • Natural Biomaterial

Mode of Delivery Insights:

  • Balloon-Expandable Stents

  • Self-Expanding Stents

End User Insights:

  • Hospitals

  • Ambulatory Surgical Centers

  • Others

Regional Insights:

  • Kanto Region

  • Kinki Region

  • Central/Chubu Region

  • Kyushu-Okinawa Region

  • Tohoku Region

  • Chugoku Region

  • Hokkaido Region

  • Shikoku Region

Ask Analyst for Sample Report: https://www.imarcgroup.com/request?type=report&id=18300&flag=C

Competitive Landscape

The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant. Additionally, the report features detailed profiles of major companies in the Japan coronary stents industry.

  • Medtronic Japan Co. Ltd. (Medtronic plc)

  • Terumo Corporation

Key Highlights of the Report:

  • Market Performance (2019-2024)

  • Market Outlook (2025-2033)

  • COVID-19 Impact on the Market

  • Porter’s Five Forces Analysis

  • Strategic Recommendations

  • Historical, Current, and Future Market Trends

  • Market Drivers and Success Factors

  • SWOT Analysis

  • Structure of the Market

  • Value Chain Analysis

  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:                                                                                

Street: 563-13 Kamien

Area: Iwata

Country: Tokyo, Japan

Postal Code: 4380111

Email: sales@imarcgroup.com

{{{ content }}}